Slingshot members are tracking this event:
Allergan (AGN) to complete Phase 3 study of of Vilazodone in Adolescent Patients With Major Depressive Disorder in summer 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Oct 06, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Study, Vilazodone, Major Depressive Disorder, Viibryd